José Luís Molinuevo

Research interests

Publications

• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

  Alzheimer s & Dementia · 2024 · https://doi.org/10.1002/alz.13859

• Dementia prevention in memory clinics: recommendations from the European task force for brain health services

  The Lancet Regional Health - Europe · 2023 · https://doi.org/10.1016/j.lanepe.2022.100576

• Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum

  JAMA Neurology · 2021 · https://doi.org/10.1001/jamaneurol.2021.3671

• Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected

  EMBO Molecular Medicine · 2020 · 10.15252/emmm.202012921

• World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia

  Alzheimer s & Dementia · 2020 · https://doi.org/10.1002/alz.12123

• The characterisation of subjective cognitive decline

  The Lancet Neurology · 2020 · https://doi.org/10.1016/s1474-4422(19)30368-0

• Dementia care during COVID-19

  The Lancet · 2020 · 10.1016/s0140-6736(20)30755-8

• Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

  Alzheimer s & Dementia · 2019 · https://doi.org/10.1016/j.jalz.2019.01.015

• Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

  Nature Reviews Neurology · 2018 · https://doi.org/10.1038/s41582-018-0079-7

• Current state of Alzheimer’s fluid biomarkers

  Acta Neuropathologica · 2018 · 10.1007/s00401-018-1932-x

• NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

  Alzheimer s & Dementia · 2018 · https://doi.org/10.1016/j.jalz.2018.02.018

• Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia

  Alzheimer s & Dementia · 2018 · 10.1016/j.jalz.2018.10.003

• Alzheimer’s disease prevention: from risk factors to early intervention

  Alzheimer s Research & Therapy · 2017 · 10.1186/s13195-017-0297-z

• Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

  The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30159-x

• Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

  JAMA Psychiatry · 2017 · https://doi.org/10.1001/jamapsychiatry.2017.3391

• Consensus guidelines for lumbar puncture in patients with neurological diseases

  Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · https://doi.org/10.1016/j.dadm.2017.04.007

• sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

  EMBO Molecular Medicine · 2016 · 10.15252/emmm.201506123

• Implementation of subjective cognitive decline criteria in research studies

  Alzheimer s & Dementia · 2016 · 10.1016/j.jalz.2016.09.012

• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

  Alzheimer s & Dementia · 2016 · https://doi.org/10.1016/j.jalz.2016.02.002

• Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review

  Alzheimer s Research & Therapy · 2015 · https://doi.org/10.1186/s13195-015-0099-0

• EFNS ‐ ENS / EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

  European Journal of Neurology · 2015 · https://doi.org/10.1111/ene.12707

• Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies

  Journal of Alzheimer s Disease · 2015 · 10.3233/jad-150154

• Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

  Alzheimer s & Dementia · 2015 · https://doi.org/10.1016/j.jalz.2015.08.003

• Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

  JAMA · 2015 · 10.1001/jama.2015.4668

• A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

  Alzheimer s & Dementia · 2014 · https://doi.org/10.1016/j.jalz.2014.01.001

• Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

  Nature Reviews Neurology · 2014 · https://doi.org/10.1038/nrneurol.2014.232

• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

  The Lancet Neurology · 2014 · https://doi.org/10.1016/s1474-4422(14)70090-0

• TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

  Science Translational Medicine · 2014 · 10.1126/scitranslmed.3009093

• Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients

  PLoS ONE · 2014 · 10.1371/journal.pone.0089741

• CSF biomarker variability in the Alzheimer's Association quality control program

  Alzheimer s & Dementia · 2013 · https://doi.org/10.1016/j.jalz.2013.01.010

• Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study

  The Lancet Neurology · 2013 · 10.1016/s1474-4422(13)70056-5

• The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

  Alzheimer s & Dementia · 2011 · https://doi.org/10.1016/j.jalz.2011.05.2243

• Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study

  The Lancet Neurology · 2010 · https://doi.org/10.1016/s1474-4422(10)70216-7

• Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP

  Neurobiology of Aging · 2008 · https://doi.org/10.1016/j.neurobiolaging.2008.06.012

• Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

  The Lancet Neurology · 2006 · 10.1016/s1474-4422(06)70476-8

Current projects

No projects listed.